Uterine sarcoma: twenty-seven years of experience

L Livi, F Paiar, N Shah, P Blake, A Villanucci… - International Journal of …, 2003 - Elsevier
PURPOSE: A correlation of treatment for uterine sarcoma with outcome, prognostic
importance of pathology, and clinical parameters. PATIENTS AND METHODS: One hundred …

[HTML][HTML] Tumour-infiltrating gamma/delta T-lymphocytes are correlated with a brief disease-free interval in advanced ovarian serous carcinoma

…, DR Degl'Innocenti, G Amunni, A Villanucci… - Annals of oncology, 2005 - Elsevier
Background Significant progress has been made in understanding the molecular biology of
ovarian carcinoma. Along with the molecular characteristics of cancer, the patient's response …

Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma

MR Raspollini, G Amunni, A Villanucci… - International Journal of …, 2004 - ijgc.bmj.com
The aim of the study was to test the prognostic value of the microvessel density (MVD) within
the tumor and the vascular endothelial growth factor (VEGF) expression on clinical response …

Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome

MR Raspollini, G Amunni, A Villanucci, V Boddi… - Gynecologic …, 2004 - Elsevier
Objectives. Cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) play a
critical role in cancer development. We investigated iNOS and COX-2 expression in relation …

Breast reconstruction actualized in nipple-sparing mastectomy and direct-to-implant, prepectoral polyurethane positioning: early experience and preliminary results

R de Vita, EM Buccheri, A Villanucci, M Pozzi - Clinical Breast Cancer, 2019 - Elsevier
Background Implant-based breast reconstruction after nipple-sparing mastectomy has been
the most common breast reconstruction procedure performed, for both breast cancer …

[HTML][HTML] c-KIT expression and correlation with chemotherapy resistance in ovarian carcinoma: an immunocytochemical study

MR Raspollini, G Amunni, A Villanucci, G Baroni… - Annals of oncology, 2004 - Elsevier
Background Recent studies have shown that several tumours express c-KIT, a growth factor
receptor with tyrosine kinase activity; moreover, clinical results have shown the efficacy of …

Increased cyclooxygenase-2 (COX-2) and P-glycoprotein-170 (MDR1) expression is associated with chemotherapy resistance and poor prognosis. Analysis in …

MR Raspollini, G Amunni, A Villanucci… - International Journal of …, 2005 - ijgc.bmj.com
The aim of the study is to test the prognostic value of cyclooxygenase-2 (COX-2) and P-
glycoprotein in relation to responsiveness to chemotherapy in ovarian carcinoma patients …

A European, observational, prospective trial of trabectedin plus pegylated liposomal doxorubicin in patients with platinum‐sensitive ovarian cancer

S Pignata, G Scambia, A Villanucci, E Naglieri… - The …, 2021 - academic.oup.com
Purpose The noninterventional, prospective NIMES‐ROC phase IV study (NCT02825420)
evaluated trabectedin plus pegylated liposomal doxorubicin (PLD) in real‐life clinical …

c-Kit expression in patients with uterine leiomyosarcomas: a potential alternative therapeutic treatment

MR Raspollini, G Amunni, A Villanucci, P Pinzani… - Clinical cancer …, 2004 - AACR
Purpose: Uterine leiomyosarcomas are rare tumors characterized by their resistance to
chemotherapy and radiation treatment. Surgery is the primary method of treatment, but for …

Utility of CDX-2 in distinguishing between primary and secondary (intestinal) mucinous ovarian carcinoma: an immunohistochemical comparison of 43 cases

MR Raspollini, G Amunni, A Villanucci… - Applied …, 2004 - journals.lww.com
Primary and secondary mucinous tumors can involve the ovaries and have similar histologic
appearances. The differential diagnosis is important for surgical and chemotherapeutic …